The global artificial intelligence (AI) in drug discovery market size is accounted at USD 6.93 billion in 2025 and is forecasted to hit around USD 16.52 billion by 2034, representing a CAGR of 10.10% from 2025 to 2034. The North America market size was estimated at USD 3.72 billion in 2024 and is expanding at a CAGR of 10.20% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. End User Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) In Drug Discovery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) In Drug Discovery Market, by Type
8.1.1. Preclinical and Clinical Testing
8.1.1.1. Market Revenue and Forecast
8.1.2. Molecule Screening
8.1.2.1. Market Revenue and Forecast
8.1.3. Target Identification
8.1.3.1. Market Revenue and Forecast
8.1.4. De Novo Drug Design and Drug Optimization
8.1.4.1. Market Revenue and Forecast
9.1. Artificial Intelligence (AI) In Drug Discovery Market, by Application
9.1.1. Neurology
9.1.1.1. Market Revenue and Forecast
9.1.2. Infectious Disease
9.1.2.1. Market Revenue and Forecast
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. Artificial Intelligence (AI) In Drug Discovery Market, by Drug Type
10.1.1. Small Molecules
10.1.1.1. Market Revenue and Forecast
10.1.2. Large Molecules
10.1.2.1. Market Revenue and Forecast
11.1. Artificial Intelligence (AI) In Drug Discovery Market, by Offering
11.1.1. Software
11.1.1.1. Market Revenue and Forecast
11.1.2. Services
11.1.2.1. Market Revenue and Forecast
12.1. Artificial Intelligence (AI) In Drug Discovery Market, by Technology
12.1.1. Machine Learning
12.1.1.1. Market Revenue and Forecast
12.1.2. Other Technologies
12.1.2.1. Market Revenue and Forecast
13.1. Artificial Intelligence (AI) In Drug Discovery Market, by End User
13.1.1. Pharmaceutical & Biotechnology Companies
13.1.1.1. Market Revenue and Forecast
13.1.2. Contract Research Organizations
13.1.2.1. Market Revenue and Forecast
13.1.3. Academics & Research
13.1.3.1. Market Revenue and Forecast
13.1.4. Others
13.1.4.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type
14.1.2. Market Revenue and Forecast, by Application
14.1.3. Market Revenue and Forecast, by Drug Type
14.1.4. Market Revenue and Forecast, by Offering
14.1.5. Market Revenue and Forecast, by Technology
14.1.6. Market Revenue and Forecast, by End User
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Type
14.1.7.2. Market Revenue and Forecast, by Application
14.1.7.3. Market Revenue and Forecast, by Drug Type
14.1.7.4. Market Revenue and Forecast, by Offering
14.1.8. Market Revenue and Forecast, by Technology
14.1.8.1. Market Revenue and Forecast, by End User
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type
14.1.9.2. Market Revenue and Forecast, by Application
14.1.9.3. Market Revenue and Forecast, by Drug Type
14.1.9.4. Market Revenue and Forecast, by Offering
14.1.10. Market Revenue and Forecast, by Technology
14.1.11. Market Revenue and Forecast, by End User
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type
14.2.2. Market Revenue and Forecast, by Application
14.2.3. Market Revenue and Forecast, by Drug Type
14.2.4. Market Revenue and Forecast, by Offering
14.2.5. Market Revenue and Forecast, by Technology
14.2.6. Market Revenue and Forecast, by End User
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type
14.2.8.2. Market Revenue and Forecast, by Application
14.2.8.3. Market Revenue and Forecast, by Drug Type
14.2.9. Market Revenue and Forecast, by Offering
14.2.10. Market Revenue and Forecast, by Technology
14.2.10.1. Market Revenue and Forecast, by End User
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Type
14.2.11.2. Market Revenue and Forecast, by Application
14.2.11.3. Market Revenue and Forecast, by Drug Type
14.2.12. Market Revenue and Forecast, by Offering
14.2.13. Market Revenue and Forecast, by Technology
14.2.14. Market Revenue and Forecast, by End User
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Type
14.2.15.2. Market Revenue and Forecast, by Application
14.2.15.3. Market Revenue and Forecast, by Drug Type
14.2.15.4. Market Revenue and Forecast, by Offering
14.2.16. Market Revenue and Forecast, by Technology
14.2.16.1. Market Revenue and Forecast, by End User
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Type
14.2.17.2. Market Revenue and Forecast, by Application
14.2.17.3. Market Revenue and Forecast, by Drug Type
14.2.17.4. Market Revenue and Forecast, by Offering
14.2.18. Market Revenue and Forecast, by Technology
14.2.18.1. Market Revenue and Forecast, by End User
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type
14.3.2. Market Revenue and Forecast, by Application
14.3.3. Market Revenue and Forecast, by Drug Type
14.3.4. Market Revenue and Forecast, by Offering
14.3.5. Market Revenue and Forecast, by Technology
14.3.6. Market Revenue and Forecast, by End User
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Type
14.3.7.2. Market Revenue and Forecast, by Application
14.3.7.3. Market Revenue and Forecast, by Drug Type
14.3.7.4. Market Revenue and Forecast, by Offering
14.3.8. Market Revenue and Forecast, by Technology
14.3.9. Market Revenue and Forecast, by End User
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Type
14.3.10.2. Market Revenue and Forecast, by Application
14.3.10.3. Market Revenue and Forecast, by Drug Type
14.3.10.4. Market Revenue and Forecast, by Offering
14.3.11. Market Revenue and Forecast, by Technology
14.3.11.1. Market Revenue and Forecast, by End User
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Type
14.3.12.2. Market Revenue and Forecast, by Application
14.3.12.3. Market Revenue and Forecast, by Drug Type
14.3.12.4. Market Revenue and Forecast, by Offering
14.3.12.5. Market Revenue and Forecast, by Technology
14.3.12.6. Market Revenue and Forecast, by End User
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Type
14.3.13.2. Market Revenue and Forecast, by Application
14.3.13.3. Market Revenue and Forecast, by Drug Type
14.3.13.4. Market Revenue and Forecast, by Offering
14.3.13.5. Market Revenue and Forecast, by Technology
14.3.13.6. Market Revenue and Forecast, by End User
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type
14.4.2. Market Revenue and Forecast, by Application
14.4.3. Market Revenue and Forecast, by Drug Type
14.4.4. Market Revenue and Forecast, by Offering
14.4.5. Market Revenue and Forecast, by Technology
14.4.6. Market Revenue and Forecast, by End User
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Type
14.4.7.2. Market Revenue and Forecast, by Application
14.4.7.3. Market Revenue and Forecast, by Drug Type
14.4.7.4. Market Revenue and Forecast, by Offering
14.4.8. Market Revenue and Forecast, by Technology
14.4.9. Market Revenue and Forecast, by End User
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Type
14.4.10.2. Market Revenue and Forecast, by Application
14.4.10.3. Market Revenue and Forecast, by Drug Type
14.4.10.4. Market Revenue and Forecast, by Offering
14.4.11. Market Revenue and Forecast, by Technology
14.4.12. Market Revenue and Forecast, by End User
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Type
14.4.13.2. Market Revenue and Forecast, by Application
14.4.13.3. Market Revenue and Forecast, by Drug Type
14.4.13.4. Market Revenue and Forecast, by Offering
14.4.13.5. Market Revenue and Forecast, by Technology
14.4.13.6. Market Revenue and Forecast, by End User
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Type
14.4.14.2. Market Revenue and Forecast, by Application
14.4.14.3. Market Revenue and Forecast, by Drug Type
14.4.14.4. Market Revenue and Forecast, by Offering
14.4.14.5. Market Revenue and Forecast, by Technology
14.4.14.6. Market Revenue and Forecast, by End User
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type
14.5.2. Market Revenue and Forecast, by Application
14.5.3. Market Revenue and Forecast, by Drug Type
14.5.4. Market Revenue and Forecast, by Offering
14.5.5. Market Revenue and Forecast, by Technology
14.5.6. Market Revenue and Forecast, by End User
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Type
14.5.7.2. Market Revenue and Forecast, by Application
14.5.7.3. Market Revenue and Forecast, by Drug Type
14.5.7.4. Market Revenue and Forecast, by Offering
14.5.8. Market Revenue and Forecast, by Technology
14.5.8.1. Market Revenue and Forecast, by End User
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type
14.5.9.2. Market Revenue and Forecast, by Application
14.5.9.3. Market Revenue and Forecast, by Drug Type
14.5.9.4. Market Revenue and Forecast, by Offering
14.5.9.5. Market Revenue and Forecast, by Technology
14.5.9.6. Market Revenue and Forecast, by End User
15.1. NVIDIA CORPORATION
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Microsoft Corporation
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. INSILICO MEDICINE INC.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Schrödinger
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. EXSCIENTIA
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Cloud Pharmaceuticals
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. TOMWISE, INC
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample